Clinical Trial Update: A Study of LM-350 in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

LaNova Medicines is conducting a Phase 1/2 study of LM-350 in adults with advanced solid tumors, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LM-350

Snippet

Sponsor: LaNova Medicines Limited | Conditions: Malignant Tumors | Phase 1, Phase 2 | Status: RECRUITING